project id: TCGA-LUAD; case submitter id: TCGA-91-7771; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 62; days to birth: -22926; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 22926; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 492.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: Not Reported; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; cigarettes per day: 4.109589041095891; pack years smoked: 75.0; is ffpe: false; composition: Not Reported; intermediate dimension: 0.9; longest dimension: 3.0; preservation method: Unknown; shortest dimension: 0.6; sample id: 25b98904-0171-403a-a66f-11f586ecf8c0; sample submitter id: TCGA-91-7771-01A; portion id: 5164505c-eac6-4b75-9df3-41efd0ede7bd; portion submitter id: TCGA-91-7771-01A-11; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 61.0;